Huntington's Net Interest Income Growth Faces Its First Real Test
Huntington Bancshares (HBAN) reports second-quarter earnings before the market opens on July 23, 2026, with analysts expecting continued momentum in a regional banking sector navigating interest rate dynamics and credit quality concerns. The central question: can HBAN sustain its recent earnings trajectory while managing net interest margin pressures and demonstrating loan growth in a competitive environment? With the stock trading above all key moving averages and analyst sentiment strongly bullish, this report will test whether the regional bank can justify its recent rally.
Part 1: Earnings Preview
Huntington Bancshares is a regional bank holding company operating primarily across the Midwest and Mid-Atlantic, providing consumer and commercial banking services, wealth management, and payment processing solutions. The company serves approximately 11 million customers through its branch network and digital channels, making it a significant player in the regional banking landscape.
HBAN is scheduled to report second-quarter 2026 earnings before the market opens on July 23, 2026. Analysts expect earnings per share of $0.39, based on a consensus of 6 estimates ranging from $0.38 to $0.39. The company most recently reported first-quarter EPS of $0.37, which beat the $0.36 estimate by 2.78%. Compared to the same quarter last year when HBAN earned $0.38 per share, the current estimate represents 2.63% year-over-year growth—modest but positive momentum in a challenging rate environment.
Three key themes define this earnings story:
Net Interest Margin Stabilization: With the Federal Reserve's rate policy evolving through 2026, investors are focused on whether HBAN can stabilize or expand its net interest margin after quarters of compression. The bank's deposit mix and loan repricing dynamics will be critical indicators of profitability trajectory.
Credit Quality and Loan Loss Provisions: Regional banks face heightened scrutiny over commercial real estate exposure and consumer credit trends. HBAN's provision levels and non-performing asset ratios will signal management's confidence in the credit cycle and could drive significant post-earnings volatility.
Expense Management and Efficiency: With revenue growth constrained by the rate environment, investors are watching whether HBAN can deliver operating leverage through disciplined expense control. The efficiency ratio and commentary on technology investments versus branch optimization will be key.
Analyst commentary ahead of the release reflects cautious optimism. The 14 Strong Buy ratings among 20 total recommendations suggest confidence in HBAN's execution, with the $20.40 mean price target implying meaningful upside. However, the recent shift from 15 to 14 Strong Buys indicates some analysts are taking a more measured stance as the stock has appreciated. Consensus estimates have been revised upward from $0.38 to $0.39 for the quarter, suggesting improving visibility into the bank's performance.
Part 2: Historical Earnings Performance
HBAN has demonstrated mixed but generally positive earnings execution over the past four quarters. The company has beaten or met estimates in three of the last four reports, with the most notable performance coming in Q3 2025 when it delivered $0.40 versus the $0.38 estimate—a 5.26% beat. The Q4 2025 miss of -5.13% ($0.37 actual vs. $0.39 estimate) stands as the only significant disappointment in the recent sequence.
The trend shows improving consistency in recent quarters. After the Q4 2025 stumble, HBAN returned to form with a modest 2.78% beat in Q1 2026 ($0.37 vs. $0.36 estimate). The year-ago quarter (Q2 2025) saw the company meet expectations exactly at $0.38, suggesting management has historically been conservative in guiding this particular quarter. The pattern indicates HBAN tends to deliver results within a narrow range of estimates—typically within $0.02 per share—rather than producing dramatic surprises in either direction.
What's particularly notable is the sequential earnings stability: reported EPS has ranged only from $0.37 to $0.40 over the past four quarters, demonstrating the steady, predictable earnings profile typical of well-managed regional banks. This consistency, combined with the recent upward revision in estimates from $0.38 to $0.39, suggests analysts have confidence in HBAN's ability to navigate the current operating environment.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.38 | $0.38 | unch | Beat |
| Sep 2025 | $0.38 | $0.40 | +5.26% | Beat |
| Dec 2025 | $0.39 | $0.37 | -5.13% | Miss |
| Mar 2026 | $0.36 | $0.37 | +2.78% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
HBAN reports before the market opens, meaning Day 0 captures the market's immediate reaction in the first full trading session after results are released, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-23 | +$0.01 (+0.06%) | $0.70 (4.16%) | -$0.43 (-2.55%) | $0.47 (2.82%) |
| 2026-01-22 | -$1.13 (-6.02%) | $0.82 (4.34%) | -$0.29 (-1.64%) | $0.50 (2.86%) |
| 2025-10-17 | +$0.13 (+0.85%) | $0.48 (3.16%) | +$0.34 (+2.19%) | $0.27 (1.74%) |
| 2025-07-18 | -$0.27 (-1.59%) | $0.67 (3.95%) | +$0.10 (+0.60%) | $0.40 (2.39%) |
| 2025-04-17 | +$0.40 (+3.01%) | $0.42 (3.17%) | -$0.20 (-1.46%) | $0.28 (2.05%) |
| 2025-01-17 | +$0.17 (+1.01%) | $0.43 (2.58%) | +$0.09 (+0.53%) | $0.33 (1.94%) |
| 2024-10-17 | -$0.41 (-2.59%) | $0.44 (2.78%) | -$0.07 (-0.45%) | $0.37 (2.40%) |
| 2024-07-19 | +$0.56 (+3.92%) | $0.49 (3.43%) | +$0.15 (+1.01%) | $0.35 (2.36%) |
| Avg Abs Move | 2.38% | 3.44% | 1.31% | 2.32% |
The historical price action reveals significant volatility on earnings day with more muted follow-through. HBAN has averaged an absolute move of 2.38% on Day 0 with an intraday range of 3.44%, indicating substantial initial reactions to quarterly results. The Day +1 average absolute move of 1.31% with a 2.32% range suggests momentum typically moderates after the initial response.
The most recent report (April 2026) exemplified this pattern: a minimal +0.06% Day 0 move masked a 4.16% intraday range, followed by a -2.55% decline on Day +1. The January 2026 report produced the largest recent reaction with a -6.02% Day 0 drop, though this was followed by only a -1.64% Day +1 move. Positive earnings surprises have also generated meaningful moves—the July 2024 report jumped 3.92% on Day 0 after a beat.
Investors should anticipate potential for a 2-3% move in either direction on earnings day, with the stock's recent pattern suggesting larger moves tend to occur when results deviate meaningfully from expectations. The relatively wide intraday ranges indicate active trading and position adjustments throughout the earnings session.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 30) |
| Expected Move | $1.03 (5.60%) |
| Expected Range | $17.33 to $19.39 |
| Implied Volatility | 28.14% |
The options market is pricing a 5.60% expected move through the August 21 expiration—substantially higher than the 2.38% average historical Day 0 move. This elevated implied volatility of 28.14% suggests options traders are anticipating a larger-than-typical reaction, possibly reflecting uncertainty around net interest margin guidance or credit quality metrics that could drive outsized moves.
Part 3: What Analysts Are Saying
Analyst sentiment on HBAN remains strongly bullish heading into earnings. The current average recommendation of 4.45 reflects solid buy-side conviction, with 14 Strong Buy ratings, 1 Moderate Buy, and 5 Hold ratings among 20 analysts covering the stock. Notably, there are zero sell ratings, indicating no analysts are outright bearish on the regional bank's prospects.
The consensus has deteriorated slightly over the past month, with the average recommendation declining from 4.55 to 4.45 as one analyst downgraded from Strong Buy. This modest shift suggests some profit-taking or caution as the stock has rallied, but the overall stance remains decidedly positive.
The mean price target of $20.40 implies 11.4% upside from the current price of $18.32, with the range spanning from a low of $18.50 to a high of $22.50. This relatively tight clustering of targets—with even the low estimate suggesting minimal downside—reflects analyst confidence in HBAN's valuation support. The high target of $22.50 would represent 22.8% upside, indicating the most bullish analysts see significant appreciation potential if the company can execute on margin expansion and loan growth initiatives.
Part 4: Technical Picture
HBAN enters earnings with strong technical momentum across all timeframes. The Barchart Technical Opinion currently stands at 80% Buy, up sharply from 72% Buy one week ago and 24% Buy one month ago—a dramatic strengthening that reflects accelerating bullish sentiment as the stock has broken out to new highs.
Timeframe Analysis:
- Short-term (100% Buy): Maximum bullish signal indicates powerful near-term momentum heading into the earnings release
- Medium-term (75% Buy): Strong buy signal confirms the intermediate trend remains firmly positive
- Long-term (50% Buy): Moderate buy signal suggests the longer-term trend is constructive but less emphatic than shorter timeframes
Trend Characteristics: The Strong strength rating combined with Strongest direction indicates HBAN is in a robust uptrend with accelerating momentum—a technically favorable setup for an earnings catalyst.
The stock is trading above all major moving averages, a bullish alignment that confirms trend strength. HBAN sits above its 5-day MA ($18.27), 10-day MA ($18.09), 20-day MA ($17.95), 50-day MA ($16.98), 100-day MA ($16.56), and 200-day MA ($16.76). The widening gap between the current price and longer-term averages—particularly the 7.9% premium to the 50-day and 9.3% premium to the 200-day—demonstrates sustained buying pressure over recent months.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $18.27 | 50-Day MA | $16.98 |
| 10-Day MA | $18.09 | 100-Day MA | $16.56 |
| 20-Day MA | $17.95 | 200-Day MA | $16.76 |
The ascending moving average structure with all shorter-term averages above longer-term ones confirms a healthy uptrend without concerning divergences. The 50-day MA crossing above the 200-day MA earlier this year formed a golden cross that has supported the rally. Key support now sits at the $17.95 20-day MA, which has contained pullbacks during the recent advance. The technical setup is decidedly supportive heading into earnings, though the extended nature of the rally above all moving averages means a disappointing report could trigger profit-taking back toward the $17.95-$18.09 support zone. Conversely, a strong beat with positive guidance could propel HBAN toward the $19.39 upper end of the options-implied range and challenge the $20.40 analyst target.